Quantitative Detection of BCR-ABL1, Minor Form (p190)
Ordering Recommendation
This quantitative test is appropriate for therapeutic monitoring of BCR-ABL1 minor (p190) positive chronic myeloid leukemia (CML) or acute lymphoblastic leukemia/lymphoma (ALL).
For patients with uncertain diagnoses or unknown forms of BCR-ABL1 fusion transcripts, consider ordering Diagnostic Qualitative BCR-ABL1 Assay with Reflex to p190 or p210 Quantitative Assays (3005839).
New York DOH Approval Status
Specimen Required
Whole blood or bone marrow in lavender (EDTA).
Whole Blood: Transport 5 mL whole blood. (Min: 3 mL)
Bone Marrow: Transport 3 mL bone marrow. (Min: 1 mL)
Refrigerate immediately. Specimens must be received within 48 hours of collection due to lability of RNA.
Whole Blood or Bone Marrow: CRITICAL REFRIGERATED. Separate specimens must be submitted when multiple tests are ordered.
Serum, plasma, extracted DNA, CSF, FFPE tissue, ambient whole blood, or frozen whole blood or bone marrow.
Specimens collected in anticoagulants other than EDTA. Severely hemolyzed or clotted specimens.
Ambient bone marrow specimens past 7 days will be canceled.
Refrigerated whole blood or bone marrow specimens past 7 days will be canceled.
Ambient: Unacceptable; Refrigerated: 48 hours; Frozen: Unacceptable
Methodology
Quantitative Reverse Transcription Polymerase Chain Reaction
Performed
Varies
Reported
5-9 days
Reference Interval
Interpretive Data
Refer to report.
Laboratory Developed Test (LDT)
Note
For p210 fusion form (major breakpoint), order BCR-ABL1, Major (p210), Quantitative (ARUP test code 3005840).
Hotline History
Hotline History
CPT Codes
81207
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
3016971 | Quant BCR-ABL1, Minor (p190), Source | 31208-2 |
3016972 | Quant BCR-ABL1, Minor (p190), Result | 21823-0 |
3016973 | Quant BCR-ABL1, Minor (p190), Ratio | 52132-8 |
3016975 | Quant BCR-ABL1, Minor (p190), EER | 11526-1 |
Aliases
- Minor
- p190
- Ph+
- philadelphia chromosome
- t(9;22)